JPH06507604A - 黄体形成ホルモン放出ホルモン拮抗ペプチド - Google Patents
黄体形成ホルモン放出ホルモン拮抗ペプチドInfo
- Publication number
- JPH06507604A JPH06507604A JP4505977A JP50597792A JPH06507604A JP H06507604 A JPH06507604 A JP H06507604A JP 4505977 A JP4505977 A JP 4505977A JP 50597792 A JP50597792 A JP 50597792A JP H06507604 A JPH06507604 A JP H06507604A
- Authority
- JP
- Japan
- Prior art keywords
- sequence position
- alanine
- residue
- peptides
- lysine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (11)
- 1.構造が、配列番号:1である黄体形成ホルモン放出ホルモン拮抗ペプチドで あり、この場合、配列位置1におけるアラニン残基は、N−アセチル−D−3− (2−ナフチル)−アラニン;配列位置2におけるフェニルアラニン残基は、D −3−(4−クロロフェニル)−アラニン配列位置3におけるアラニン残基は、 D−3−(3−ピリジル)−アラニン;配列位置6におけるリジン残基は、6− カルバモイルリジン;配列位置8におけるリジン残基は、N−イソプロピル−リ ジン;および配列位置10におけるアラニン残基は、D−Ala−NH2である 。
- 2.薬学的に受容可能な塩の形における請求の範囲1のペプチド。
- 3.該薬学的に受容可能な塩が、パモ酸もしくはステアリン酸塩である請求の範 囲2のペプチド。
- 4.構造が、配列番号:2である黄体形成ホルモン放出ホルモン拮抗ペプチドで あり、この場合、配列位置1におけるアラニン残基は、N−アセチル−D−3− (2−ナフチル)−アラニン;配列位置2におけるフェニルアラニン残基は、D −3−(4−クロロフェニル)−アラニン;配列位置3におけるアラニン残基は 、D−3−(3−ピリジル)−アラニン;配列位置6におけるリジン残基は、6 −カルバモイルリジン;配列位置8におけるリジン残基は、N−イソプロピル− リジン;および配列位置9におけるプロリン残基は、Pro−NHCH2CH3 である。
- 5.薬学的に受容可能な塩の形における請求の範囲4のペプチド。
- 6.該薬学的に受容可能な塩が、パモ酸もしくはステアリン酸塩である請求の範 囲5のペプチド。
- 7.薬学的に受容可能なキャリヤーとともに混合された請求の範囲1〜4のペプ チドを成分として含有する薬学的調合剤。
- 8.基剤として生分解性および生物適合性ポリマーよりなる、請求の範囲1〜4 のペプチドの非経口的投与のために好ましい投薬システム。
- 9.薬学的に受容可能なペプチダーゼ阻害剤とともに混合された請求の範囲1〜 4のペプチドの鼻内投与のために好ましい薬学的調合品。
- 10.薬学的に受容可能な粘膜浸透促進剤とともに混合された請求の範囲1〜4 のペプチドの鼻内投与のために好ましい薬学的調合品。
- 11.血漿エストロゲンおよびアンドロゲンレベルを実質的に減少させるための 薬物の作成のための請求の範囲1〜4のペプチドの使用。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69086191A | 1991-04-25 | 1991-04-25 | |
US690,861 | 1991-04-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH06507604A true JPH06507604A (ja) | 1994-09-01 |
JP2719233B2 JP2719233B2 (ja) | 1998-02-25 |
Family
ID=24774274
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP4505977A Expired - Fee Related JP2719233B2 (ja) | 1991-04-25 | 1992-03-17 | 黄体形成ホルモン放出ホルモン拮抗ペプチド |
Country Status (12)
Country | Link |
---|---|
US (1) | US5516887A (ja) |
EP (1) | EP0593491B1 (ja) |
JP (1) | JP2719233B2 (ja) |
AT (1) | ATE144538T1 (ja) |
AU (1) | AU1371892A (ja) |
CA (1) | CA2108977C (ja) |
DE (2) | DE593491T1 (ja) |
DK (1) | DK0593491T3 (ja) |
ES (1) | ES2052488T3 (ja) |
GR (2) | GR940300048T1 (ja) |
HK (1) | HK1006172A1 (ja) |
WO (1) | WO1992019651A1 (ja) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6225431B1 (en) * | 1991-07-05 | 2001-05-01 | Biocompatibles Limited | Biocompatibilizing process |
US6284854B1 (en) * | 1991-07-05 | 2001-09-04 | Biccompatibles Limited | Polymeric surface coatings |
US5843901A (en) * | 1995-06-07 | 1998-12-01 | Advanced Research & Technology Institute | LHRH antagonist peptides |
DE19544212A1 (de) * | 1995-11-28 | 1997-06-05 | Asta Medica Ag | Neue LH-RH-Antagonisten mit verbesserter Wirkung |
US5821230A (en) * | 1997-04-11 | 1998-10-13 | Ferring Bv | GnRH antagonist decapeptides |
US5925730A (en) * | 1997-04-11 | 1999-07-20 | Ferring Bv | GnRH antagonists |
CN1307481A (zh) * | 1998-04-27 | 2001-08-08 | 普雷西斯药品公司 | 用于治疗热潮红和男子女性型乳房的方法 |
US6235776B1 (en) | 1998-11-12 | 2001-05-22 | Cell Pathways, Inc. | Method for treating a patient with neoplasia by treatment with a paclitaxel derivative |
US6235782B1 (en) | 1998-11-12 | 2001-05-22 | Rifat Pamukcu | Method for treating a patient with neoplasia by treatment with a platinum coordination complex |
US6703367B1 (en) * | 1999-04-27 | 2004-03-09 | Praecis Pharmaceuticals Inc. | Methods for treating hot flashes and gynaecomastia |
NZ521273A (en) | 2000-03-14 | 2005-01-28 | Zentaris Gmbh | Novel LHRH-antagonists, production and use thereof as medicament for hormone-dependant tumors, endometriosis, beign prostate hyperplasia and fertility disorders |
AU2001269439A1 (en) * | 2000-07-05 | 2002-01-14 | Takeda Chemical Industries Ltd. | Medicinal preparations for treating sex hormone-dependent diseases |
GB0117057D0 (en) * | 2001-07-12 | 2001-09-05 | Ferring Bv | Pharmaceutical composition |
US7098305B2 (en) * | 2001-09-06 | 2006-08-29 | Ardana Bioscience Limited | Sustained release of microcrystalline peptide suspensions |
WO2006010155A2 (en) | 2004-07-16 | 2006-01-26 | Oakwood Laboratories, L.L.C | Gonadotropin releasing hormone antagonists |
TWI442932B (zh) | 2008-02-11 | 2014-07-01 | Ferring Int Ct Sa | 以GnRH拮抗劑治療攝護腺癌的方法 |
EP2424503B1 (en) * | 2009-05-01 | 2017-07-05 | Ferring BV | Composition for the treatment of prostate cancer |
TW201043221A (en) * | 2009-05-06 | 2010-12-16 | Ferring Int Ct Sa | Kit and method for preparation of a Degarelix solution |
US20110039787A1 (en) * | 2009-07-06 | 2011-02-17 | Ferring International Center S.A. | Compositions, kits and methods for treating benign prostate hyperplasia |
PL2632934T3 (pl) | 2010-10-27 | 2017-06-30 | Ferring B.V. | Sposób wytwarzania degareliksu i jego związków pośrednich |
EP2447276A1 (en) | 2010-10-27 | 2012-05-02 | Ferring B.V. | Process for the manufacture of Degarelix and its intermediates |
JO3755B1 (ar) | 2011-01-26 | 2021-01-31 | Ferring Bv | تركيبات تستوستيرون |
AR092840A1 (es) | 2012-06-01 | 2015-05-06 | Ferring Bv | Elaboracion de degarelix |
EP3307262B1 (en) | 2015-06-15 | 2021-05-19 | NMD Pharma A/S | Compounds for use in treating neuromuscular disorders |
US11730714B2 (en) | 2017-12-14 | 2023-08-22 | Nmd Pharma A/S | Compounds for the treatment of neuromuscular disorders |
US11147788B2 (en) | 2017-12-14 | 2021-10-19 | Nmd Pharma A/S | Compounds for the treatment of neuromuscular disorders |
CN113527438A (zh) * | 2021-08-30 | 2021-10-22 | 湖南三太药业有限公司 | 一种全液相合成丙氨瑞林的方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4740500A (en) * | 1985-01-31 | 1988-04-26 | The Salk Institute For Biological Studies | GnRH antagonists VIII |
US5003011A (en) * | 1985-04-09 | 1991-03-26 | The Administrators Of The Tulane Educational Fund | Therapeutic decapeptides |
US4801577A (en) * | 1987-02-05 | 1989-01-31 | Syntex (U.S.A.) Inc. | Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists |
US4851385A (en) * | 1987-07-15 | 1989-07-25 | Indiana University Foundation | LHRH antagonist analogs having low histamine-release activity |
US4800191A (en) * | 1987-07-17 | 1989-01-24 | Schally Andrew Victor | LHRH antagonists |
US4935491A (en) * | 1987-08-24 | 1990-06-19 | Board Of Regents, The University Of Texas System | Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine |
US5110904A (en) * | 1989-08-07 | 1992-05-05 | Abbott Laboratories | Lhrh analogs |
-
1992
- 1992-03-17 DE DE0593491T patent/DE593491T1/de active Pending
- 1992-03-17 AT AT92906562T patent/ATE144538T1/de not_active IP Right Cessation
- 1992-03-17 ES ES92906562T patent/ES2052488T3/es not_active Expired - Lifetime
- 1992-03-17 WO PCT/EP1992/000572 patent/WO1992019651A1/en active IP Right Grant
- 1992-03-17 US US08/140,045 patent/US5516887A/en not_active Expired - Lifetime
- 1992-03-17 EP EP92906562A patent/EP0593491B1/en not_active Expired - Lifetime
- 1992-03-17 CA CA002108977A patent/CA2108977C/en not_active Expired - Fee Related
- 1992-03-17 AU AU13718/92A patent/AU1371892A/en not_active Abandoned
- 1992-03-17 JP JP4505977A patent/JP2719233B2/ja not_active Expired - Fee Related
- 1992-03-17 DK DK92906562.1T patent/DK0593491T3/da active
- 1992-03-17 DE DE69214818T patent/DE69214818T2/de not_active Expired - Fee Related
-
1994
- 1994-07-29 GR GR940300048T patent/GR940300048T1/el unknown
-
1996
- 1996-12-23 GR GR960403590T patent/GR3022144T3/el unknown
-
1998
- 1998-06-15 HK HK98105279A patent/HK1006172A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU1371892A (en) | 1992-12-21 |
DE69214818D1 (de) | 1996-11-28 |
WO1992019651A1 (en) | 1992-11-12 |
US5516887A (en) | 1996-05-14 |
DK0593491T3 (da) | 1997-03-17 |
HK1006172A1 (en) | 1999-02-12 |
GR3022144T3 (en) | 1997-03-31 |
ES2052488T3 (es) | 1997-01-01 |
JP2719233B2 (ja) | 1998-02-25 |
DE69214818T2 (de) | 1997-02-27 |
ATE144538T1 (de) | 1996-11-15 |
CA2108977C (en) | 2002-12-17 |
DE593491T1 (de) | 1994-11-17 |
ES2052488T1 (es) | 1994-07-16 |
EP0593491B1 (en) | 1996-10-23 |
GR940300048T1 (en) | 1994-07-29 |
CA2108977A1 (en) | 1992-10-26 |
EP0593491A1 (en) | 1994-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH06507604A (ja) | 黄体形成ホルモン放出ホルモン拮抗ペプチド | |
Reissmann et al. | The LHRH antagonist cetrorelix: a review | |
US4010125A (en) | [D-Trp6 ]-LH-RH and intermediates therefor | |
US5763404A (en) | Methods for using LHRH antagonists with low histamine release | |
US6747125B1 (en) | Peptide intermediates for making GnRH antagonists | |
EP0796622B1 (en) | The use of a gonadotropin releasing hormone analog or mime thereof for the preparation of a pharmaceutical composition as an adjunctive for the invasive treatment of carcinomas | |
JPH0791314B2 (ja) | Lhrh拮抗体として有用なlhrhのノナペプチドおよびデカペプチド類似体 | |
JPS6356238B2 (ja) | ||
US4338305A (en) | Use of LRH and LRH agonists | |
PT682524E (pt) | Composicoes farmaceuticas que contem a proteina bactericida indutora da permeabilidade e um agente tensioactivo | |
US4018726A (en) | [D-Phe6 ]-LH-RH and intermediates therefor | |
TW577735B (en) | Pharmaceutical combined preparation and its use in the treatment of gynaecological disorders | |
KR0123009B1 (ko) | 쥐이엔알에이취(GnRH) 유사체 | |
US4024121A (en) | (Pyro)-Glu-His-Trp-D-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHR and intermediates | |
US5580957A (en) | GnRH analogs | |
JPS6022720B2 (ja) | ペプチドおよびその製法 | |
WO2003075958A1 (fr) | Medicaments permettant de traiter une maladie dependant d'une hormone sexuelle | |
US4443368A (en) | Peptides affecting gonadal function | |
CZ84893A3 (en) | Method of projecting and synthesizing lhrh antagonists | |
Ip et al. | Antitumor efficacy in rats of CGP 19984, a thiazolidinedione derivative that inhibits luteinizing hormone secretion | |
US4377574A (en) | Contraceptive treatment of male mammals | |
KR100210472B1 (ko) | 황체형성 호르몬 분비 호르몬 길항 펩티드 | |
AU2002368261A1 (en) | Long-acting gonadotropin-releasing hormone analogs and methods of use thereof | |
US4489061A (en) | Treatment of male mammals | |
US5382568A (en) | Decapeptide having dopamine stimulating activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081114 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091114 Year of fee payment: 12 |
|
LAPS | Cancellation because of no payment of annual fees |